Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse
The Consortium jointly, through Aztiq II HoldCo, has completed the acquisition of a 100% stake in Alvogen Emerging Markets Holdings Limited, thereby becoming the leading shareholders in Lotus Pharmaceuticals and Adalvo Róbert Wessman, Chairman and CEO of Alvogen and Founder of Aztiq Pharma Partners, will continue as Chairman of the board of...
AffaMed Therapeutics Holds DEXTENZA Launch and Advisory Board Meeting in Macau
SHANGHAI, May 10, 2022 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global clinical-stage biopharmaceutical company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products, held a DEXTENZA Launch and Advisory Board Meeting recently in Macau, following DEXTENZA's approval for the treatment of post-surgical ocular pain and inflammation. Dr. Iat Fan Lai from Kiang Wu Hospital, Dr. John Hovanesian from Harvard Eye Association,...
Formus Labs, a Pioneering Developer of Orthopedic Surgery Planning Technology, Hires Ex-Johnson & Johnson Executive, Polly Teevan, To Lead Global Commercial Strategy
Having managed a nearly $1 billion business in the world's largest orthopedic market, Teevan brings 20+ years of experience to help Formus improve patient lives AUCKLAND, New Zealand, May 10, 2022 /PRNewswire/ -- Formus Labs, creator of the world's first fully-automated 3D planner for joint replacement surgeries, today announced it has hired Polly Teevan as Chief Marketing Officer. Teevan will...
U.S. Centers for Disease Control and Prevention Selects Biobot Analytics to Expand National Wastewater Monitoring
CAMBRIDGE, Mass., May 10, 2022 /PRNewswire/ -- The U.S. Centers for Disease Control (CDC) has selected Biobot Analytics to expand the agency's National Wastewater Surveillance System (NWSS), an integral part of President Biden's plan to fight Covid-19 and prepare the country for future pandemics. NWSS works with public health departments across the...
iNtRON Biotechnology, Inc., Launches New Website
It aims to promote strategic collaborations in global while also highlights its many innovative advances and successful scientific ventures. BOSTON and SEOUL, South Korea, May 9, 2022 /PRNewswire/ -- The parent company of iNtODEWORLD, Inc., iNtRON Biotechnology, Inc., ("iNtRON" or "Company") is thrilled to announce the launch of its new website, http://www.intodeworld.com. iNtRON is a leading bio-venture company focused on...
Brii Bio Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, Retains Neutralizing Activity Against Omicron BA.2 Subvariant
Studies conducted by independent labs demonstrate the amubarvimab/romlusevimab combination retains neutralizing activity against COVID-19 Omicron variant Review of the monoclonal antibody combination therapy is underway by the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization DURHAM, N.C. and BEIJING, May 9, 2022 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or...
OBiO Technology to Present Data on OVersatile™ Platform for Process Development of Herpes Simplex Virus and Vaccinia Virus Products at the 25th ASGCT Annual Meeting
SHANGHAI, May 9, 2022 /PRNewswire/ -- OBiO Technology (Shanghai) Corp., Ltd. ('OBiO', SSE:688238.SH), a gene and cell therapy-focused biotechnology company, serving as a contract research organization for vectorology and functional genomics studies, and providing contract development and manufacturing services of IND-enabling CMC, clinical and commercial manufacturing, today announced that research on...
Series A financing round lays foundation for international growth of digital cancer therapeutics Mika
New investors with a successful track record in digital oncology support German Digital Therapeutics (DTx) company Fosanis to broaden patient access of Mika – an app-based DTx platform empowering people affected by cancer. BERLIN, LAUSANNE,Switzerland, BARCELONA,Spain and MUNICH, May 9, 2022 /PRNewswire/ -- Berlin-based digital health company Fosanis, the developer of Mika, Germany's first prescription DTx for all oncological...
Zepp Health Corp. to Report First Quarter 2022 Financial Results on May 24, 2022
Earnings Call Scheduled for 8:00 a.m. ET on May 24, 2022 BEIJING, May 9, 2022 /PRNewswire/ -- Zepp Health Corp. ("Zepp Health" or the "Company") (NYSE: ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its first quarter 2022 unaudited financial results before the market open on Tuesday, May 24, 2022. Management will...
Premix signs $79.9 million contract for a new production facility in the U.S.
The major agreement will help secure critical diagnostic supplies in the United States and better serve Premix's global customers GASTONIA, N.C. and HELSINKI, May 9, 2022 /PRNewswire/ -- The U.S. Department of Defense, working with the Department of Health and Human Services, awarded a $79.9 million contract to Premix, Inc. to establish a plastic compound manufacturing plant in North...
